Michael Rapé
Consultant / Advisor presso MONTE ROSA THERAPEUTICS, INC.
Profilo
Michael Rapé is the founder of Nurix Therapeutics, Inc. (founded in 2009) and Lyterian Therapeutics, Inc. (founded in 2022).
He is currently the Head & Division of Molecular Therapeutics at the University of California, Berkeley since 2022.
He is also an iPartner at The Column Group LLC since 2021, a Scientific Advisor at Monte Rosa Therapeutics, Inc. since 2020, and a Scientific Advisor at Berkeley Frontier Fund.
Additionally, he is a Member & Scientific Advisory Board at Vicinitas Therapeutics since 2022.
Dr. Rapé obtained his doctorate degree from the Max Planck Institute of Biochemistry in 2002.
Posizioni attive di Michael Rapé
| Società | Posizione | Inizio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consultant / Advisor | 01/09/2020 |
Berkeley Frontier Fund
 Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Consultant / Advisor | - |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Private Equity Investor | 01/01/2021 |
Vicinitas Therapeutics
 Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Consultant / Advisor | 01/07/2022 |
| University of California, Berkeley | Corporate Officer/Principal | 01/07/2022 |
Precedenti posizioni note di Michael Rapé
| Società | Posizione | Fine |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Founder | - |
Formazione di Michael Rapé
| Max Planck Institute of Biochemistry | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NURIX THERAPEUTICS, INC. | Health Technology |
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
The Column Group LLC
The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco. | Finance |
Berkeley Frontier Fund
Berkeley Frontier Fund Investment ManagersFinance Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California. | Finance |
Vicinitas Therapeutics
Vicinitas Therapeutics BiotechnologyHealth Technology Vicinitas Therapeutics is located in the US. Vicinitas Therapeutics is an American US-based biotechnology company that specializes in developing next-generation disease therapies using targeted protein stabilizers called Deubiquituinase Targeting Chimeras (DUBtacs). The company's mission is to solve critical problems in human health by developing disease therapies against an entire class of previously inaccessible disease-causing proteins. | Health Technology |
- Borsa valori
- Insiders
- Michael Rapé
